Podcasts about Chemistry

In our end-of-week episode, Jamie Steyer Johnson and Brittany Carper recap Thursday's doubleheader, where the Minnesota Lynx defeated the Los Angeles Sparks and the Washington Mystics topped the Las Vegas Aces. They also take a deep dive into Los Angeles, examining how the Sparks seem to be finding their rhythm as we approach the midseason point.HerHoopStats.comUnlock better insight about the women's game.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Melissa and Jam delve into the fascinating chemistry behind film photography. They reminisce about their childhood experiences with analog cameras and discuss the shift to digital cameras. Melissa, a chemist, explains the complex chemical processes involved in capturing and developing photos on film, focusing on the role of light-sensitive silver bromide. The episode also includes shout-outs to community members who spurred the topic and closes with personal stories and favorite film photos. Get ready to explore the intersection of chemistry and photography while revisiting nostalgia from the days of film cameras. 00:00 Nostalgia: From Film to Digital Cameras 00:38 The Shift to Digital Photography 01:52 Introduction to the Podcast 02:01 Shoutouts and Listener Requests 12:32 The Chemistry Behind Film Photography 28:03 Amplifying the Latent Image 28:24 Creating the Negative 29:11 Fixing the Image 29:51 Understanding the Negative 30:30 Inverting the Negative 31:15 Early Photography Challenges 32:12 Explaining the Process 33:21 Chemical Reactions in Film Development 34:44 Scanning and Developing Film 41:15 Personal Film Photography Stories 51:29 Supporting the Show ★ Support this podcast on Patreon ★ ★ Buy Podcast Merch and Apparel ★ Check out our website at chemforyourlife.com Watch our episodes on YouTube Find us on Instagram, Twitter, and Facebook @ChemForYourLife References from this episode: https://pubs-acs-org.libproxy.library.unt.edu/doi/epdf/10.1021/ed052p622?ref=article_openPDF https://pubs-acs-org.libproxy.library.unt.edu/doi/10.1021/acs.jchemed.6b00400 https://pubs-acs-org.libproxy.library.unt.edu/doi/10.1021/ed081p694 https://edu.rsc.org/experiments/making-a-photographic-print-using-silver-chloride/454.article https://www.acs.org/content/dam/acsorg/education/resources/highschool/chemmatters/articlesbytopic/metals%20and%20nonmetals/chemmatters-feb2006-digital-photo.pdf https://www.researchgate.net/profile/Rolf-Steiger/publication/279964154_CHEMICAL_SENSITIZATION_OF_SILVER_BROMIDE/links/5a7d8b55aca272341aef2f6f/CHEMICAL-SENSITIZATION-OF-SILVER-BROMIDE.pdf https://www.acs.org/education/celebrating-chemistry-editions/2024-ncw/chemistry-of-polaroids.html https://cen.acs.org/articles/87/i12/Instant-Film.html https://www.acs.org/education/whatischemistry/landmarks/land-instant-photography.html https://pubs-acs-org.libproxy.library.unt.edu/doi/epdf/10.1021/ed051p72?ref=article_openPDF Thanks to our monthly supporters Vince W Julie S. Heather R Autoclave Chelsea M Dorien VD Scott B Jessie R Ciara L J0HNTR0Y Jeannette N Cullyn R Erica B Elizabeth P Sarah M Rachel R Letila Katrina B Suzanne P Venus R Lyn S Jacob T Brian K Emerson W Kristina G Timothy P Steven B Chris and Claire S Chelsea B Avishai B Hunter R ★ Support this podcast on Patreon ★ ★ Buy Podcast Merch and Apparel ★ Check out our website at chemforyourlife.com Watch our episodes on YouTube Find us on Instagram, Twitter, and Facebook @ChemForYourLife

What is the cause of the Red Sox' newfound chemistry?

Sometimes sex feels like love or chemistry but that is not the only kind of intimacy there is.  But you might get caught in a cycle where you are leading with sex to get a connection and in the end not finding the right partner for you.  And then, you might shut down and be nervous about showing your flirty, sexy side after being hurt.  In Episode 402 of The Charisma Quotient, “When Sex Feels Like Love: Breaking the Cycle of Fast-Tracked Intimacy” Kimmy does a live coaching session with Nicolle, a vibrant and self-assured woman who has embraced her sexuality for years, brings a unique perspective to the conversation.   After years of leading with sex and enjoying pleasure for her own sake—not for love—Nicolle finds herself in a new chapter. She's now seeking a meaningful relationship but feels unprepared when it comes to the art of dating and emotional pacing. Nicolle candidly shares her experiences: from disappointing app dates and challenges around being truly seen as a plus-size woman, to her struggles with playfulness and letting her sensual, flirty nature shine without fear of being objectified.   Kimmy and Nicolle dive deep into the balance of maintaining a sexy, playful energy while also requiring potential partners to earn intimacy and trust. Kimmy offers practical strategies—like finding your conscious tribe, practicing self-focused dating, and building authentic emotional intimacy—as she reflects on reclaiming her sense of self.    You'll hear: Why so many women confuse sex with love—and how childhood experiences shape this belief Body image realities: what it's really like dating as a plus-size woman who feels sexy, but battles internalized doubts Real-world app dating struggles—and the differences between authentic connection and transactional “hookup culture” The importance of expressing your emotions instead of always describing or interviewing, and how this shift makes you magnetic   If you relate to some of Nicolle's story and feel confused about how to safely show your sexy side, come to Kimmy's next co-ed workshop Unleash Your Sexy Confidence: The Art of Attraction and Chemistry. to get you out there to find opportunities to build your confidence and have fun in the process.  You'll learn EXACTLY what you need to know and do in order to turn yourself into a sexy magnet.  Go to www.stophatingdating.com to register now. Charisma Quotient Podcast is available on Apple Podcasts, Spotify, and many of your other favorite podcast channels. ************************************************⁣ Kimmy Seltzer is a Confidence Therapist and Authentic Dating Strategist implementing targeted style, emotional and social intelligence to your life. ⁣ ************************************************⁣ Would you like to connect with Kimmy?⁣ Website:  https://kimmyseltzer.com/⁣ Chat:  https://meetme.so/kimbreakthrough⁣ Instagram: @kimmyseltzer Twitter: @kimmyseltzer Join her FREE Facebook Group Love Makeover Insiders:  https://www.facebook.com/groups/lovemakeovers Take her Flirt Quiz to see what kind of flirt you are www.flirtover40.com

Dr. Paul Hanona and Dr. Arturo Loaiza-Bonilla discuss how to safely and smartly integrate AI into the clinical workflow and tap its potential to improve patient-centered care, drug development, and access to clinical trials. TRANSCRIPT Dr. Paul Hanona: Hello, I'm Dr. Paul Hanona, your guest host of the ASCO Daily News Podcast today. I am a medical oncologist as well as a content creator @DoctorDiscover, and I'm delighted to be joined today by Dr. Arturo Loaiza-Bonilla, the chief of hematology and oncology at St. Luke's University Health Network. Dr. Bonilla is also the co-founder and chief medical officer at Massive Bio, an AI-driven platform that matches patients with clinical trials and novel therapies. Dr. Loaiza-Bonilla will share his unique perspective on the potential of artificial intelligence to advance precision oncology, especially through clinical trials and research, and other key advancements in AI that are transforming the oncology field. Our full disclosures are available in the transcript of the episode. Dr. Bonilla, it's great to be speaking with you today. Thanks for being here. Dr. Arturo Loaiza-Bonilla: Oh, thank you so much, Dr. Hanona. Paul, it's always great to have a conversation. Looking forward to a great one today. Dr. Paul Hanona: Absolutely. Let's just jump right into it. Let's talk about the way that we see AI being embedded in our clinical workflow as oncologists. What are some practical ways to use AI? Dr. Arturo Loaiza-Bonilla: To me, responsible AI integration in oncology is one of those that's focused on one principle to me, which is clinical purpose is first, instead of the algorithm or whatever technology we're going to be using. If we look at the best models in the world, they're really irrelevant unless we really solve a real day-to-day challenge, either when we're talking to patients in the clinic or in the infusion chair or making decision support. Currently, what I'm doing the most is focusing on solutions that are saving us time to be more productive and spend more time with our patients. So, for example, we're using ambient AI for appropriate documentation in real time with our patients. We're leveraging certain tools to assess for potential admission or readmission of patients who have certain conditions as well. And it's all about combining the listening of physicians like ourselves who are end users, those who create those algorithms, data scientists, and patient advocates, and even regulators, before they even write any single line of code. I felt that on my own, you know, entrepreneurial aspects, but I think it's an ethos that we should all follow. And I think that AI shouldn't be just bolted on later. We always have to look at workflows and try to look, for example, at clinical trial matching, which is something I'm very passionate about. We need to make sure that first, it's easier to access for patients, that oncologists like myself can go into the interface and be able to pull the data in real time when you really need it, and you don't get all this fatigue alerts. To me, that's the responsible way of doing so. Those are like the opportunities, right? So, the challenge is how we can make this happen in a meaningful way – we're just not reacting to like a black box suggestion or something that we have no idea why it came up to be. So, in terms of success – and I can tell you probably two stories of things that we know we're seeing successful – we all work closely with radiation oncologists, right? So, there are now these tools, for example, of automated contouring in radiation oncology, and some of these solutions were brought up in different meetings, including the last ASCO meeting. But overall, we know that transformer-based segmentation tools; transformer is just the specific architecture of the machine learning algorithm that has been able to dramatically reduce the time for colleagues to spend allotting targets for radiation oncology. So, comparing the target versus the normal tissue, which sometimes it takes many hours, now we can optimize things over 60%, sometimes even in minutes. So, this is not just responsible, but it's also an efficiency win, it's a precision win, and we're using it to adapt even mid-course in response to tumor shrinkage. Another success that I think is relevant is, for example, on the clinical trial matching side. We've been working on that and, you know, I don't want to preach to the choir here, but having the ability for us to structure data in real time using these tools, being able to extract information on biomarkers, and then show that multi-agentic AI is superior to what we call zero-shot or just throwing it into ChatGPT or any other algorithm, but using the same tools but just fine-tuned to the point that we can be very efficient and actually reliable to the level of almost like a research coordinator, is not just theory. Now, it can change lives because we can get patients enrolled in clinical trials and be activated in different places wherever the patient may be. I know it's like a long answer on that, but, you know, as we talk about responsible AI, that's important. And in terms of what keeps me up at night on this: data drift and biases, right? So, imaging protocols, all these things change, the lab switch between different vendors, or a patient has issues with new emerging data points. And health systems serve vastly different populations. So, if our models are trained in one context and deployed in another, then the output can be really inaccurate. So, the idea is to become a collaborative approach where we can use federated learning and patient-centricity so we can be much more efficient in developing those models that account for all the populations, and any retraining that is used based on data can be diverse enough that it represents all of us and we can be treated in a very good, appropriate way. So, if a clinician doesn't understand why a recommendation is made, as you probably know, you probably don't trust it, and we shouldn't expect them to. So, I think this is the next wave of the future. We need to make sure that we account for all those things. Dr. Paul Hanona: Absolutely. And even the part about the clinical trials, I want to dive a little bit more into in a few questions. I just kind of wanted to make a quick comment. Like you said, some of the prevalent things that I see are the ambient scribes. It seems like that's really taken off in the last year, and it seems like it's improving at a pretty dramatic speed as well. I wonder how quickly that'll get adopted by the majority of physicians or practitioners in general throughout the country. And you also mentioned things with AI tools regarding helping regulators move things quicker, even the radiation oncologist, helping them in their workflow with contouring and what else they might have to do. And again, the clinical trials thing will be quite interesting to get into. The first question I had subsequent to that is just more so when you have large datasets. And this pertains to two things: the paper that you published recently regarding different ways to use AI in the space of oncology referred to drug development, the way that we look at how we design drugs, specifically anticancer drugs, is pretty cumbersome. The steps that you have to take to design something, to make sure that one chemical will fit into the right chemical or the structure of the molecule, that takes a lot of time to tinker with. What are your thoughts on AI tools to help accelerate drug development? Dr. Arturo Loaiza-Bonilla: Yes, that's the Holy Grail and something that I feel we should dedicate as much time and effort as possible because it relies on multimodality. It cannot be solved by just looking at patient histories. It cannot be solved by just looking at the tissue alone. It's combining all these different datasets and being able to understand the microenvironment, the patient condition and prior treatments, and how dynamic changes that we do through interventions and also exposome – the things that happen outside of the patient's own control – can be leveraged to determine like what's the best next step in terms of drugs. So, the ones that we heard the news the most is, for example, the Nobel Prize-winning [for Chemistry awarded to Demis Hassabis and John Jumper for] AlphaFold, an AI system that predicts protein structures right? So, we solved this very interesting concept of protein folding where, in the past, it would take the history of the known universe, basically – what's called the Levinthal's paradox – to be able to just predict on amino acid structure alone or the sequence alone, the way that three-dimensionally the proteins will fold. So, with that problem being solved and the Nobel Prize being won, the next step is, “Okay, now we know how this protein is there and just by sequence, how can we really understand any new drug that can be used as a candidate and leverage all the data that has been done for many years of testing against a specific protein or a specific gene or knockouts and what not?” So, this is the future of oncology and where we're probably seeing a lot of investments on that. The key challenge here is mostly working on the side of not just looking at pathology, but leveraging this digital pathology with whole slide imaging and identifying the microenvironment of that specific tissue. There's a number of efforts currently being done. One isn't just H&E, like hematoxylin and eosin, slides alone, but with whole imaging, now we can use expression profiles, spatial transcriptomics, and gene whole exome sequencing in the same space and use this transformer technology in a multimodality approach that we know already the slide or the pathology, but can we use that to understand, like, if I knock out this gene, how is the microenvironment going to change to see if an immunotherapy may work better, right? If we can make a microenvironment more reactive towards a cytotoxic T cell profile, for example. So, that is the way where we're really seeing the field moving forward, using multimodality for drug discovery. So, the FDA now seems to be very eager to support those initiatives, so that's of course welcome. And now the key thing is the investment to do this in a meaningful way so we can see those candidates that we're seeing from different companies now being leveraged for rare disease, for things that are going to be almost impossible to collect enough data, and make it efficient by using these algorithms that sometimes, just with multiple masking – basically, what they do is they mask all the features and force the algorithm to find solutions based on the specific inputs or prompts we're doing. So, I'm very excited about that, and I think we're going to be seeing that in the future. Dr. Paul Hanona: So, essentially, in a nutshell, we're saying we have the cancer, which is maybe a dandelion in a field of grass, and we want to see the grass that's surrounding the dandelion, which is the pathology slides. The problem is, to the human eye, it's almost impossible to look at every single piece of grass that's surrounding the dandelion. And so, with tools like AI, we can greatly accelerate our study of the microenvironment or the grass that's surrounding the dandelion and better tailor therapy, come up with therapy. Otherwise, like you said, to truly generate a drug, this would take years and years. We just don't have the throughput to get to answers like that unless we have something like AI to help us. Dr. Arturo Loaiza-Bonilla: Correct. Dr. Paul Hanona: And then, clinical trials. Now, this is an interesting conversation because if you ever look up our national guidelines as oncologists, there's always a mention of, if treatment fails, consider clinical trials. Or in the really aggressive cancers, sometimes you might just start out with clinical trials. You don't even give the standard first-line therapy because of how ineffective it is. There are a few issues with clinical trials that people might not be aware of, but the fact that the majority of patients who should be on clinical trials are never given the chance to be on clinical trials, whether that's because of proximity, right, they might live somewhere that's far from the institution, or for whatever reason, they don't qualify for the clinical trial, they don't meet the strict inclusion criteria.  But a reason you mentioned early on is that it's simply impossible for someone to be aware of every single clinical trial that's out there. And then even if you are aware of those clinical trials, to actually find the sites and put in the time could take hours. And so, how is AI going to revolutionize that? Because in my mind, it's not that we're inventing a new tool. Clinical trials have always been available. We just can't access them. So, if we have a tool that helps with access, wouldn't that be huge? Dr. Arturo Loaiza-Bonilla: Correct. And that has been one of my passions. And for those who know me and follow me and we've spoke about it in different settings, that's something that I think we can solve. This other paradox, which is the clinical trial enrollment paradox, right? We have tens of thousands of clinical trials available with millions of patients eager to learn about trials, but we don't enroll enough and many trials close to accrual because of lack of enrollment. It is completely paradoxical and it's because of that misalignment because patients don't know where to go for trials and sites don't know what patients they can help because they haven't reached their doors yet. So, the solution has to be patient-centric, right? We have to put the patient at the center of the equation. And that was precisely what we had been discussing during the ASCO meeting. There was an ASCO Education Session where we talked about digital prescreening hubs, where we, in a patient-centric manner, the same way we look for Uber, Instacart, any solution that you may think of that you want something that can be leveraged in real time, we can use these real-world data streams from the patient directly, from hospitals, from pathology labs, from genomics companies, to continuously screen patients who can match to the inclusion/exclusion criteria of unique trials. So, when the patient walks into the clinic, the system already knows if there's a trial and alerts the site proactively. The patient can actually also do decentralization. So, there's a number of decentralized clinical trial solutions that are using what I call the “click and mortar” approach, which is basically the patient is checking digitally and then goes to the site to activate. We can also have the click and mortar in the bidirectional way where the patient is engaged in person and then you give the solution like the ones that are being offered on things that we're doing at Massive Bio and beyond, which is having the patient to access all that information and then they make decisions and enroll when the time is right.  As I mentioned earlier, there is this concept drift where clinical trials open and close, the patient line of therapy changes, new approvals come in and out, and sites may not be available at a given time but may be later. So, having that real-time alerts using tools that are able already to extract data from summarization that we already have in different settings and doing this natural language ingestion, we can not only solve this issue with manual chart review, which is extremely cumbersome and takes forever and takes to a lot of one-time assessments with very high screen failures, to a real-time dynamic approach where the patient, as they get closer to that eligibility criteria, they get engaged. And those tools can be built to activate trials, audit trials, and make them better and accessible to patients. And something that we know is, for example, 91%-plus of Americans live close to either a pharmacy or an imaging center. So, imagine that we can potentially activate certain of those trials in those locations. So, there's a number of pharmacies, special pharmacies, Walgreens, and sometimes CVS trying to do some of those efforts. So, I think the sky's the limit in terms of us working together. And we've been talking with corporate groups, they're all interested in those efforts as well, to getting patients digitally enabled and then activate the same way we activate the NCTN network of the corporate groups, that are almost just-in-time. You can activate a trial the patient is eligible for and we get all these breakthroughs from the NIH and NCI, just activate it in my site within a week or so, as long as we have the understanding of the protocol. So, using clinical trial matching in a digitally enabled way and then activate in that same fashion, but not only for NCTN studies, but all the studies that we have available will be the key of the future through those prescreening hubs. So, I think now we're at this very important time where collaboration is the important part and having this silo-breaking approach with interoperability where we can leverage data from any data source and from any electronic medical records and whatnot is going to be essential for us to move forward because now we have the tools to do so with our phones, with our interests, and with the multiple clinical trials that are coming into the pipelines. Dr. Paul Hanona: I just want to point out that the way you described the process involves several variables that practitioners often don't think about. We don't realize the 15 steps that are happening in the background. But just as a clarifier, how much time is it taking now to get one patient enrolled on a clinical trial? Is it on the order of maybe 5 to 10 hours for one patient by the time the manual chart review happens, by the time the matching happens, the calls go out, the sign-up, all this? And how much time do you think a tool that could match those trials quicker and get you enrolled quicker could save? Would it be maybe an hour instead of 15 hours? What's your thought process on that? Dr. Arturo Loaiza-Bonilla: Yeah, exactly. So one is the matching, the other one is the enrollment, which, as you mentioned, is very important. So, it can take, from, as you said, probably between 4 days to sometimes 30 days. Sometimes that's how long it takes for all the things to be parsed out in terms of logistics and things that could be done now agentically. So, we can use agents to solve those different steps that may take multiple individuals. We can just do it as a supply chain approach where all those different steps can be done by a single agent in a simultaneous fashion and then we can get things much faster. With an AI-based solution using these frontier models and multi-agentic AI – and we presented some of this data in ASCO as well – you can do 5,000 patients in an hour, right? So, just enrolling is going to be between an hour and maximum enrollment, it could be 7 days for those 5,000 patients if it was done at scale in a multi-level approach where we have all the trials available. Dr. Paul Hanona: No, definitely a very exciting aspect of our future as oncologists. It's one thing to have really neat, novel mechanisms of treatment, but what good is it if we can't actually get it to people who need it? I'm very much looking for the future of that.  One of the last questions I want to ask you is another prevalent way that people use AI is just simply looking up questions, right? So, traditionally, the workflow for oncologists is maybe going on national guidelines and looking up the stage of the cancer and seeing what treatments are available and then referencing the papers and looking at who was included, who wasn't included, the side effects to be aware of, and sort of coming up with a decision as to how to treat a cancer patient. But now, just in the last few years, we've had several tools become available that make getting questions easier, make getting answers easier, whether that's something like OpenAI's tools or Perplexity or Doximity or OpenEvidence or even ASCO has a Guidelines Assistant as well that is drawing from their own guidelines as to how to treat different cancers. Do you see these replacing traditional sources? Do you see them saving us a lot more time so that we can be more productive in clinic? What do you think is the role that they're going to play with patient care? Dr. Arturo Loaiza-Bonilla: Such a relevant question, particularly at this time, because these AI-enabled query tools, they're coming left and right and becoming increasingly common in our daily workflows and things that we're doing. So, traditionally, when we go and we look for national guidelines, we try to understand the context ourselves and then we make treatment decisions accordingly. But that is a lot of a process that now AI is helping us to solve. So, at face value, it seems like an efficiency win, but in many cases, I personally evaluate platforms as the chief of hem/onc at St. Luke's and also having led the digital engagement things through Massive Bio and trying to put things together, I can tell you this: not all tools are created equal. In cancer care, each data point can mean the difference between cure and progression, so we cannot really take a lot of shortcuts in this case or have unverified output. So, the tools are helpful, but it has to be grounded in truth, in trusted data sources, and they need to be continuously updated with, like, ASCO and NCCN and others. So, the reason why the ASCO Guidelines Assistant, for instance, works is because it builds on all these recommendations, is assessed by end users like ourselves. So, that kind of verification is critical, right? We're entering a phase where even the source material may be AI-generated. So, the role of human expert validation is really actually more important, not less important. You know, generalist LLMs, even when fine-tuned, they may not be enough. You can pull a few API calls from PubMed, etc., but what we need now is specialized, context-aware, agentic tools that can interpret multimodal and real-time clinical inputs. So, something that we are continuing to check on and very relevant to have entities and bodies like ASCO looking into this so they can help us to be really efficient and really help our patients. Dr. Paul Hanona: Dr. Bonilla, what do you want to leave the listener with in terms of the future direction of AI, things that we should be cautious about, and things that we should be optimistic about? Dr. Arturo Loaiza-Bonilla: Looking 5 years ahead, I think there's enormous promise. As you know, I'm an AI enthusiast, but always, there's a few priorities that I think – 3 of them, I think – we need to tackle head-on. First is algorithmic equity. So, most AI tools today are trained on data from academic medical centers but not necessarily from community practices or underrepresented populations, particularly when you're looking at radiology, pathology, and what not. So, those blind spots, they need to be filled, and we can eliminate a lot of disparities in cancer care. So, those frameworks to incentivize while keeping the data sharing using federated models and things that we can optimize is key. The second one is the governance on the lifecycle. So, you know, AI is not really static. So, unlike a drug that is approved and it just, you know, works always, AI changes. So, we need to make sure that we have tools that are able to retrain and recall when things degrade or models drift. So, we need to use up-to-date AI for clinical practice, so we are going to be in constant revalidation and make it really easy to do. And lastly, the human-AI interface. You know, clinicians don't need more noise or we don't need more black boxes. We need decision support that is clear, that we can interpret, and that is actionable. “Why are you using this? Why did we choose this drug? Why this dose? Why now?” So, all these things are going to help us and that allows us to trace evidence with a single click. So, I always call it back to the Moravec's paradox where we say, you know, evolution gave us so much energy to discern in the sensory-neural and dexterity. That's what we're going to be taking care of patients. We can use AI to really be a force to help us to be better clinicians and not to really replace us. So, if we get this right and we decide for transparency with trust, inclusion, etc., it will never replace any of our work, which is so important, as much as we want, we can actually take care of patients and be personalized, timely, and equitable. So, all those things are what get me excited every single day about these conversations on AI. Dr. Paul Hanona: All great thoughts, Dr. Bonilla. I'm very excited to see how this field evolves. I'm excited to see how oncologists really come to this field. I think with technology, there's always a bit of a lag in adopting it, but I think if we jump on board and grow with it, we can do amazing things for the field of oncology in general. Thank you for the advancements that you've made in your own career in the field of AI and oncology and just ultimately with the hopeful outcomes of improving patient care, especially cancer patients. Dr. Arturo Loaiza-Bonilla: Thank you so much, Dr. Hanona. Dr. Paul Hanona: Thanks to our listeners for your time today. If you value the insights that you hear on ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:    Dr. Arturo Loaiza-Bonilla @DrBonillaOnc Dr. Paul Hanona @DoctorDiscover on YouTube Follow ASCO on social media:      @ASCO on Twitter      ASCO on Facebook      ASCO on LinkedIn    ASCO on BlueSky Disclosures: Paul Hanona: No relationships to disclose. Dr. Arturo-Loaiza-Bonilla: Leadership: Massive Bio Stock & Other Ownership Interests: Massive Bio Consulting or Advisory Role: Massive Bio, Bayer, PSI, BrightInsight, CardinalHealth, Pfizer, AstraZeneca, Medscape Speakers' Bureau: Guardant Health, Ipsen, AstraZeneca/Daiichi Sankyo, Natera

Dr. Nancy Grechko, PSY, explores how attachment wounds and nervous system dysregulation may draw clients to intense, but harmful, relationships, and how clinicians can gently intervene in support of safety and stability. Interview with Elizabeth Irias, LMFT. Earn CE credit for listening to this episode by joining our low-cost membership for unlimited podcast CE credits for an entire year, with some of the strongest CE approvals in the country (APA, NBCC, ASWB, and more). Learn, grow, and shine with Clearly Clinical Continuing Ed by visiting https://ClearlyClinical.com.

What if the most powerful medicine for your heart, hormones, and longevity was already inside you? Oxytocin—often called the “love hormone”—isn't just about romance or bonding. It's a powerful neurochemical that supports emotional resilience, lowers stress, improves heart health, and may even extend your life. In this conversation, we explore how oxytocin connects the science of healing with the soul of connection. You'll learn how to naturally elevate your oxytocin through simple daily practices—touch, trust, purpose, and presence—and why love truly is medicine. Whether you're focused on healing, healthy aging, or deepening your relationships, this episode offers tools to elevate your life from the inside out. #Oxytocin #HeartHealth #Longevity #LoveHormone #EmotionalWellness #NaturalHealing #HealthyAging #MindBodyMedicine #FunctionalMedicine #HormoneHealth #Resilience #RelationshipHealth #Neuropeptide #StressRelief

In this week's episode, Shantal, Lynnie, and Gary answer even more fan-submitted questions—from what makes a hookup truly unforgettable to how many “okay” dates is too many before moving on. They are talking sex confidence vs. physical skill, the surprising impact of rejection, and why the first kiss might—or might not—tell you everything you need to know. Want your question answered on a future episode? Submit it at coffeeandcleavage.com.

Caroline O'Doherty, Environment Correspondent with the Irish Independent; and Fiona Regan, Professor in Chemistry at Dublin City University and Director of the DCU Water Institute, on possible water charges

Chemical reactions are the backbone of modern society: the energy we use, the medicines we take, our housing materials, even the foods we eat, are created by reacting different substances together. If we zoom in, it's the atoms within these substances that rearrange themselves to give rise to new substances with the properties we need. However, chemical reactions are far from perfect. They're often inefficient and their waste products can be harmful to the environment. Getting to grips with what goes on at the scale of individual atoms has long been a sticking point.Dame Pratibha Gai has spent much of her career pioneering novel microscopes to bring this seemingly inaccessible atomic world into sharp focus. Now Emeritus Professor of Chemistry at York University, her microscope, known as the environmental transmission electron microscope, is housed in labs around the world. It allows scientists, like herself, to observe chemical reactions in real-time, in exquisite atomic detail, and tinker with them to create products that are not only better for all of us, but also the environment.Presented by Jim Al-Khalili Produced by Beth Eastwood A BBC Studios Audio production for Radio 4

Monday, July 07, 2025 Inside Sports with Al Eschbach -Hot dogs and the champ, Joe C retiring, Thunder build chemistry, disappointment if they don't win championship in 2025-2026 and more. Follow the Sports Animal on Facebook, Instagram and X Follow Tony Z on Instagram and Facebook Listen to past episodes HERE! Follow Inside Sports Podcasts on Apple, Google and SpotifySee omnystudio.com/listener for privacy information.

In Part 2 of our series with Dr. Bhupinder Farmaha, we go deeper—literally. Dr. Farmaha joins us again to talk about what's happening below the topsoil and why it matters more than ever in nutrient decision-making. From soil testing at deeper depths to assessing the biological activity of soil microbes, Bhupinder's research is showing that one-size-fits-all recommendations just don't cut it anymore.He shares a bold finding: only 50% of cotton production sites in his trials respond to nitrogen application. That insight could shake up fertilizer recommendations in a big way. Bhupinder also dives into chicken litter studies, the promise and risks of micronutrient buildup, and the long-term effects of organic amendments on sandy South Carolina soils.Highlights include:Working with USDA partners to integrate biological indicators into soil testsChicken litter vs. synthetic fertilizer: trade-offs and recommendationsHow climate-smart practices can stabilize yields in unpredictable weatherRethinking seed selection in light of resilient management systemsThe episode ends with a look at where this work is headed—toward more holistic, systems-based nutrient management. Bhupinder makes a strong case for moving beyond chemistry alone and embracing biology and farmer experience as critical parts of the fertility equation.Resources Mentioned in This EpisodeCotton, Country Conservation: An 8-Year Case Study in Regenerative Agriculture (Following SC Farmer Sonny Price's path of reducing input costs, increasing organic matter, and saving over $2.5 million):  soilhealthlabs.com/projects/cotton-country-conservation

Have you ever met a teacher who just gets it—who knows how to challenge students, meet them where they are, and do it all with purpose and empathy? That's exactly who you'll hear from in this episode. I chat with Heather Bonanno, a high school chemistry teacher from Pennsylvania who recently returned to the classroom after a five-year break.Heather shares how she navigates 40-minute class periods, makes chemistry relevant through real-world connections, and uses labs to spark inquiry from day one. We also dive into her flexible approach to grading, classroom management tips, and strategies for keeping students engaged, even when the content gets tough. This episode may be about teaching chemistry on the surface, but trust me, it's so much more than that!➡️ Show Notes: https://itsnotrocketscienceclassroom.com/episode190 Resources Mentioned:Chemistry Curriculum - FULL YEAR BUNDLEChemistry Bell Ringers or Exit Slips - FULL YEAR BUNDLEDownload your FREE Classroom Reset Challenge.Take the Free Labs When Limited virtual PD courseSend me a DM on Instagram: @its.not.rocket.scienceSend me an email: rebecca@itsnotrocketscienceclassroom.com  Follow, rate, and review on Apple Podcasts.Related Episodes and Blog Posts:Episode 35, Competency, Classroom Management, Teaching Chemistry and More with Guest Zach MatsonEpisode 127, Teaching AP Chemistry with Zach MatsonEpisode 140, 5 Tips for Teaching ChemistryEpisode 186, True Life: I Am a Science Teacher Who Hates Labs

An experimental drug called NU-9 was invented at Northwestern University by Richard Silverman, PhD. It has been approved for clinical trials for the treatment of ALS and found to improves neuron health in animal models of Alzheimer's disease according to a new Northwestern Medicine study published in PNAS. This discovery is giving scientists hope that the drug could be effective in multiple neurodegenerative diseases by addressing the underlying mechanisms of these diseases. Silverman and Northwestern University Alzheimer disease expert, William Klein, PhD, discuss the potential of NU-9 in this episode.  

Jeff Blair and Kevin Barker are joined by former MLB outfielder Kevin Pillar (3:25) to chat about his decision to retire from the game of baseball, how differently he views the games now through the lens of a fan, the clubhouse experience near the trade deadline, and the importance of chemistry with his teammates. Then, former MLB president David Samson (28:38) stops by to discuss the Blue Jays hot stretch and leading the AL East, adding pitching at the deadline, how a front office analyzes their team during a winning streak, if they factor teammates' chemistry in roster decisions, Bryan Reynolds's peculiar no-trade list, and the Washington Nationals deciding to let go of both their manager and general manager halfway through the season.The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of Rogers Sports & Media or any affiliates.

BIO:    Kristen Hornung is a Licensed Professional Clinical Counselor #2071, offering in-person therapy in Encinitas and virtual therapy throughout California. She holds a Ph.D. in Depth Psychology from Pacifica Graduate Institute, an M.A. in Counseling from the University of San Diego, and a B.A. in Chemistry from Brown University. She is an EMDR Certified Therapist by EMDRIA. Kristen specializes in helping deep-thinking, over-functioning individuals with anxiety, trauma, and relationship problems.   Therapy website: https://kristenhornung.com/ Author website: https://kghornung.com/   Resources EMDR:  https://www.emdria.org/about-emdr-therapy/   Pacifica's webpage on depth psychology: https://www.pacifica.edu/about-pacifica/what-is-depth-psychology/

We have a powerful conversation about dedication, innovation, and impact in the cystic fibrosis community in this podcast. I'm joined by two incredible guests from MVW Nutritionals: Mike Walters and Jason Vandiver.Mike Walters is a true pioneer in pharmaceutical business and innovation, with nearly four decades of experience. He began his career at Johnson & Johnson, where he spent 14 years in leadership roles across sales, marketing, and management development. In 1996, Mike launched his first company to help organizations navigate product commercialization in the U.S. Since then, his work in the CF space has been nothing short of groundbreaking. He founded and led Source CF, MVW Nutritionals, and CF Global Services, playing a key role in bringing many standard-of-care treatments to market. A Vanderbilt graduate with degrees in Biochemistry and Chemistry, Mike brings both scientific insight and a deep commitment to rare disease care.Joining him is Jason Vandiver, Chief Operating Officer of MVW Nutritionals. A proud Alabama native, Jason earned his degree in Finance from the University of Alabama at Birmingham and spent 16 years in banking before joining MVW during a time of rapid growth. He now helps lead the multimillion-dollar, family-owned company that's become a global leader in nutritional products for patients with CF and non-CF EPI.In this episode, Mike and Jason share their personal stories, the importance of strong partnerships, and the real challenges patients and families are facing—especially as funding landscapes continue to shift. We explore the power of empathy, the strength of community support, and why transparency in nonprofit operations matters now more than ever.It's a conversation about hope, action, and what's ahead as we work together to support those who need us most.   Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Did you know if you don't feel an initial spark on a first date, you can actually build chemistry? Let's say you've been messaging someone on a dating app—you've been playful, curious, confident—and now you've got the first date locked in. That's exciting! But now the nerves kick in.What do you wear? What do you say? How do you actually connect in person without feeling like you're stuck in a job interview or awkwardly oversharing?Let's break it down. Because a great first date isn't about being perfect—it's about being present, genuine, and unforgettable...and hopefully building chemistry one date a time.►Please subscribe/rate and review the podcast on Apple Podcasts http://bit.ly/lastfirstdateradio ►If you're feeling stuck in dating and relationships and would like to find your last first date, sign up for a complimentary 45-minute breakthrough session with Sandy https://lastfirstdate.com/application ►Join Your Last First Date on Facebook https://facebook.com/groups/yourlastfirstdate ►Get Sandy's books, Becoming a Woman of Value; How to Thrive in Life and Love https://bit.ly/womanofvaluebook , Choice Points in Dating https://amzn.to/3jTFQe9 and Love at Last https://amzn.to/4erpj7C ►Get FREE coaching on the podcast! https://bit.ly/LFDradiocoaching ►FREE download: “Top 10 Reasons Why Men Suddenly Pull Away” http://bit.ly/whymendisappear ►Group Coaching: https://lastfirstdate.com/the-woman-of-value-club/ ►Website → https://lastfirstdate.com/ ► Instagram → https://www.instagram.com/lastfirstdate1/ ►Get Amazon Music Unlimited FREE for 30 days at https://getamazonmusic.com/lastfirstdate  

In this captivating episode of On the Brink with Andi Simon, I welcomes an unstoppable force in the world of finance, Victoria Woods—entrepreneur, wealth advisor, speaker, author, and the renowned Financial Diva. What makes Victoria's story so compelling isn't just her success in managing money for millionaires and billionaires—it's how she got there, and what she's teaching women everywhere about stepping into financial power. Victoria's journey began in humble, even challenging circumstances. Growing up poor, abandoned by her father at 11, she learned early how to hustle, survive, and eventually thrive. From organizing games for neighborhood kids to modeling for Montgomery Ward in exchange for school clothes, she was a born entrepreneur. But it was her uncanny ability to see opportunity where others saw limits that ultimately launched her into success. Women, It is Time To Master Your Money Her first “real” pivot came while working in retail. Rather than taking a promotion, she pitched a new concierge buying service to her boss—a bold move that soon had executives handing her their credit cards and letting her shop for their wardrobes. That fearless innovation caught the attention of a financial executive who saw something unique in Victoria: resilience, determination, and an uncanny knack for follow-through. He recruited her into the world of financial advising. Seven months later, Victoria took the leap—and never looked back. Now the founder and CEO of ChappelWood Financial Services in Edmond, Oklahoma, Victoria advises high-net-worth individuals, particularly women who are often underserved or underrepresented in wealth management. But her mission is broader: to educate and empower women about their finances, especially business owners who need to understand, not fear, their numbers. Watch our podcast video on YouTube here: Key Lessons from Victoria Woods on Women, Money and Mastering Your Future 1. Your Gut Is Your Superpower—But So Are Your Numbers. Victoria reminds listeners that while your instincts matter, success demands fluency in your financials. “If you're not comfortable with the numbers, you've got to get comfortable,” she says. “You should be able to read your profit and loss statements, understand your balance sheet, and question your accountant.” Her practical advice: take an accounting class—even if you're already running a company. Know your numbers or risk being run by them. 2. Don't Outsource What You Don't Understand. Too many women assume someone else—often a spouse—will handle their finances. Victoria pushes back. “90% of women will manage their own money at some point in their life,” she says. “You must know what you own, owe, spend, and invest.” Whether you're growing a business, selling one, or inheriting one, financial literacy is not optional. 3. Exit on Your Own Terms. One of Victoria's most powerful messages is about preparing for what's next. Succession planning, business exits, and legacy planning all require strategic thought before there's a crisis. “Don't plan in the middle of a tornado,” she says. “Start when the sun is shining.” She shares how she's guided women through inheriting family businesses, navigating complex buyouts, and staying strong in boardrooms full of skeptics. 4. Build Your Team with Intention. When hiring financial advisors, accountants, or legal professionals, Victoria encourages women to trust both their head and their heart. “Would you want to have dinner with this person every month?” she asks. Chemistry and clarity matter. Her book, It's All About the Money, Honey!, includes practical questions women should ask potential advisors—plus the answers they should expect to hear. 5. Serve First, Sell Second. At the heart of her success is a simple philosophy: be the easy button. Whether solving a client's complex tax issue or finding an international attorney for a property dispute, her focus is always service. That's how she built a practice with 100% retention and a global clientele. “Clients don't want more work,” she says. “They want someone who makes their lives easier.” You can read more in her book, "It's All About the Money, Honey," on Amazon. Why This Conversation about Money and Women Matters Now Women control more wealth today than at any time in history, and the number of women-owned businesses is soaring. Yet many still feel unprepared to manage that wealth with confidence. This episode is a powerful reminder that financial empowerment is about knowledge, confidence, and the courage to ask questions. As Victoria says, “Don't take advice from broke people—physically, financially, or spiritually.” Whether you're launching a startup, scaling a company, or planning a graceful exit, take time to get financially fluent. The future is female—and she should be well-funded. Learn More To learn more about Victoria Woods, visit ChappelWood.com or search for The Financial Diva online. You can also find her book It's All About the Money on Amazon and listen to selected chapters she's recorded to hear her passion and humor come alive. Ready to get off the brink? Follow the podcast for more stories of women transforming business and life—with purpose, power, and yes, profit.  Listen to these other podcasts or read the blogs about them: 438: How Nicole Loftus Is Disrupting Venture Capital 437: Erika Baez Grimes: Purpose-Driven Business Transitions 436: Women, #WorkSchoolHours Can Transform Your Life Connect with me: Website: www.simonassociates.net Email: info@simonassociates.net Books:  Learn more about our books here: Rethink: Smashing the Myths of Women in Business Women Mean Business: Over 500 Insights from Extraordinary Leaders to Spark Your Success On the Brink: A Fresh Lens to Take Your Business to New Heights Listen + Subscribe: Available wherever you get your podcasts—Apple, Spotify, Stitcher, YouTube, and more. If you enjoyed this episode, leave a review and share with someone navigating their own leadership journey. Reach out and contact us if you want to see how a little anthropology can help your business grow.  Let's Talk! From Observation to Innovation, CEO | Corporate Anthropologist | Author Simonassociates.net Info@simonassociates.net @simonandi LinkedIn  

Daniel, Skyler, Anthony, and I discussed Batman & Mr. Freeze: SubZeroFollow us! Abrar: @brownboywonderpodcast, Brownboywonders Skyler: @skyler8bit, @RSR_PodcastDaniel: @RSR_Podcast, DanielMCGAnthony: @AnthonyLantern, @AnthonyReviews, The Grud PodcastRay: @TheRaySketchesFULL BATMAN TAS SCHEDULESEASON 11. "On Leather Wings"2. "The Cat and the Claw: Part I"3. "The Cat and the Claw: Part II"4. "The Last Laugh"5. "Nothing to Fear"6. "Pretty Poison"7. "The Underdwellers"8. "P.O.V."9. "The Forgotten"10. "Be a Clown"11. "Heart of Ice"12. "Two-Face: Part I"13. "Two-Face: Part II"14. "It's Never Too Late"15. "I've Got Batman in My Basement"16. "Christmas with the Joker"17. "See No Evil"18. "Beware the Gray Ghost"19. "Feat of Clay: Part I"20. "Feat of Clay: Part II"21. "Prophecy of Doom"22. "Joker's Favor"23. "Vendetta"24. "Fear of Victory"25. "The Clock King"26. "Appointment in Crime Alley"27. "Mad as a Hatter"28. "Dreams in Darkness"29. "Eternal Youth"30. "Perchance to Dream"31. "The Cape and Cowl Conspiracy"32. "Robin's Reckoning: Part I"33. "Robin's Reckoning: Part II"34. "The Laughing Fish"35. "Night of the Ninja"36. "Cat Scratch Fever"37. "The Strange Secret of Bruce Wayne"38. "Heart of Steel: Part I"39. "Heart of Steel: Part II"40. "If You're So Smart, Why Aren't You Rich?"41. "Tyger, Tyger"42. "Joker's Wild"43. "Moon of the Wolf"44. "Day of the Samurai"45. "Terror in the Sky"46. "Almost Got 'Im"47. "Birds of a Feather"48. "What Is Reality?"49. "I Am the Night"50. "Off Balance"51. "The Man Who Killed Batman"52. "Mudslide"53. "Zatanna"54. "The Mechanic"55. "Harley and Ivy"56. "Blind as a Bat"57. "His Silicon Soul"58. "Shadow of the Bat: Part I"59. "Shadow of the Bat: Part II"60. "Fire from Olympus"61. "The Demon's Quest: Part I"62. "The Demon's Quest: Part II"63. "Read My Lips"64. "The Worry Men"65. "Paging the Crime Doctor"Batman of the Phantasm (1993) SEASON 266. "Sideshow"67. "A Bullet for Bullock"68. "Trial"69. "Avatar"70. "House & Garden"71. "The Terrible Trio"72. "Harlequinade"73. "Time Out of Joint"74. "Catwalk"75. "Bane"76. "Baby-Doll"77. "The Lion and the Unicorn"78. "Showdown"79. "Riddler's Reform"80. "Second Chance"81. "Harley's Holiday"82. "Lock-Up"83. "Make 'Em Laugh"84. "Deep Freeze"85. "Batgirl Returns"Batman & Mr. Freeze: SubZero SEASON 386. "Holiday Knights"87. "Sins of the Father"88. "Cold Comfort"89. "Double Talk"90. "You Scratch My Back"91. "Never Fear"92. "Joker's Millions"93. "Growing Pains"94. "Love Is a Croc"95. "Torch Song"96. "The Ultimate Thrill"97. "Over the Edge"98. "Mean Seasons"99. "Critters"100. "Cult of the Cat"101. "Animal Act"102. "Old Wounds"103. "The Demon Within"104. "Girl's Night Out"105. "Mad Love"106. "Chemistry"107. "Beware the Creeper"108. "Judgment Day"109. "Legends of the Dark Knight"Batman: Mystery of the Batwoman 2003

In this week's episode, both of our storytellers share tales of well-intentioned choices gone wrong.Part 1: In fourth grade, Ro Moran is thrilled to be trusted with the class pet iguana, Iggy, for the night. But by morning, something is very wrong. Part 2: As an exchange student studying superconducting oxides, Karoline Mueller tries to save money by gold-coating a cheap crucible instead of using a solid gold one. Ro is an award-winning empanada eater with a penchant for storytelling. His credits include Prose of Pie, Tiny Tales, Story Boom, Story Collider En Español, and producing the Westchester-based 'Say Word' show. He is most remembered for his groundbreaking trio with his 14yr and 3 yr old . They've since broken up due to ‘creative differences'. When Ro isn't telling tales, he is a social justice warrior for human rights non profits. Karoline is the youngest of 4 siblings. Growing up in Germany, the family interests included music, art, nature, and building things. From fairly young, there was no question in her mind but she would study music and teach private music lessons. Her plan got smashed in the audition process and she was not accepted into a conservatory program. It took her some time to recover from this huge disappointment. In a relatively random way, she stumbled on the book, Urban Systems in Crisis, by a biochemist and network thinker and was fascinated by this new way of solving problems. She was reminded of fun chemistry demonstrations and enrolled at the Saarland University in Chemistry. Despite low confidence in her English, Karoline pursued a semester abroad and came to the Texas Center for Superconductivity at the University of Houston. Delighted by the amazingly supportive mentorship at the center, she decided to return for her Ph.D. in Chemistry. She has been working there as researcher and student mentor ever since. Karoline's passion for science outreach grew over the years and now she takes great pleasure in organizing presentations and demonstrations of superconductivity.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What motivates someone to learn how to code as a scientist? How do you harness the excitement of solving problems quickly and make the connection to the benefits of coding in your scientific work? This week on the show, we speak with Ben Lear and Christopher Johnson about their book "Coding For Chemists."

Key Players Driving J.J. McCarthy's Success with the Minnesota Vikings—In this episode of The Real Forno Show, host Tyler Forness and producer Dave Stefano delve into the key Minnesota Vikings players who will be instrumental in ensuring J.J. McCarthy's success as the team's starting quarterback. While avoiding the usual focus on coaching staff, the discussion highlights players on the offensive side, such as tight end Josh Oliver and center Ryan Kelly, who will significantly impact McCarthy's performance. Other vital players like Jordan Addison, Christian Darrisaw, and T.J. Hockenson are also analyzed for their roles in supporting McCarthy's development. This episode offers a fresh perspective on how the Vikings' roster can help foster their quarterback's growth and lead the team to success. 00:00 Introduction to The Real Forno Show 00:16 Host and Show Introduction 01:36 Discussion on J.J. McCarthy's Success 02:44 Importance of Offensive Players 04:30 Josh Oliver's Role and Impact 10:16 Jordan Mason's Contribution 18:36 T.J. Hockenson's Chemistry with McCarthy 23:27 Introduction to McCarthy's Significance 23:55 McCarthy's Draft Position and Impact 24:34 Justin Jefferson's Role and Influence 25:26 Christian Darrisaw's Importance 27:20 Offensive Line Dynamics 30:21 Justin Jefferson's Potential and Challenges 36:10 Ryan Kelly's Crucial Role 40:06 Building a Strong Team Around McCarthy 43:32 Future of Quarterbacks from Last Year's Draft 46:18 Closing Remarks and 4th of July Wishes ____________________________________________________________ ⭐️ Subscribe to us here! - https://www.youtube.com/@vikings1stskol92 ⭐️ Our Twitter can be found at @Vikings1stSKOL ⭐️ Tyler Forness can be read at A to Z Sports - https://atozsports.com/nfl/minnesota-vikings-news/ ⭐️ At Fans First Sports Network - https://www.ffsn.app/teams/minnesota-vikings/ ⭐️ On Facebook - https://www.facebook.com/vikings1standskol ⭐️ Watch the live show here: https://youtu.be/ebaEZKU90W0 Learn more about your ad choices. Visit megaphone.fm/adchoices

#027 Rebroadcast Originally Published January 23, 2020 This week, Melissa and Jam dive into the chemistry of something that may not seem like chemistry at first: hair. Curly hair to be specific. What makes hair curl? Also what is hair in the first place? Why can hair be so radically different? Alright curly girls, curly guys, and curly folks, let's find out. ★ Support this podcast on Patreon ★ ★ Buy Podcast Merch and Apparel ★ Check out our website at chemforyourlife.com Watch our episodes on YouTube Find us on Instagram, Twitter, and Facebook @ChemForYourLife   References from this episode Biochemistry, Edition 4 - Garret and Grisham The Chemistry of Hair - C. S. Whewell, Ph.D., F.R.I.C., F.T.I. The Science of Curls -  Leidamarie Tirado-Lee Bad Hair Days? Chemistry to the Rescue - Marlene M. Gutierrez     Thanks to our monthly supporters Vince W Julie S. Heather R Autoclave Chelsea M Dorien VD Scott B Jessie R Ciara L J0HNTR0Y Jeannette N Cullyn R Erica B Elizabeth P Sarah M Rachel R Letila Katrina B Suzanne P Venus R Lyn S Jacob T Brian K Emerson W Kristina G Timothy P Steven B Chris and Claire S Chelsea B Avishai B Hunter R ★ Support this podcast on Patreon ★ ★ Buy Podcast Merch and Apparel ★ Check out our website at chemforyourlife.com Watch our episodes on YouTube Find us on Instagram, Twitter, and Facebook @ChemForYourLife  

Dr Shane Bergin, Physicist and Associate Professor at UCD School of Education, on the next generation of Scientists.

2PM's Ok Taecyeon And Girls' Generation's Seohyun Shock Netizens With Hot Chemistry.

Bonnie Garmus' novel Lessons in Chemistry got a lot of buzz when it was first released in 2022. Elizabeth Zott is a talented chemist but because it's the 1960s, she faces sexism in her quest to work as a scientist. So instead, she has a cooking show that is wildly popular. In this encore episode, Garmus told NPR's Scott Simon that the character of Elizabeth lived in her head for many years before she started writing this novel.To listen to Book of the Day sponsor-free and support NPR's book coverage, sign up for Book of the Day+ at plus.npr.org/bookofthedayLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Have you ever felt like you were on the outside looking in—guarded by fear, overwhelmed by old patterns, or unsure how to take that first step back into dating after heartbreak or disappointment? In Episode 401 of The Charisma Quotient, “Dating Without Attachment: Lisa's Dating Transformation Journey” In this powerful episode of the Charisma Quotient, Kimmy is joined by the inspiring Lisa, whose courageous journey from emotional pain to empowered dating will resonate with anyone who has ever felt invisible, stuck, or scared to put themselves back out there. After years of hiding behind layers of oversized clothes, fear, and insecurity, Lisa took a chance encounter into a life-changing adventure with Kimmy aired on TV NBC 9 News segments filled with self-discovery, a striking outer makeover, and the even more profound work of building her inner confidence.   In this episode, Kimmy pulls back the curtain on what it really means to "date without attachment"—a liberating approach that prioritizes curiosity and self-awareness over pressure and expectations. Listen in as Kimmy coaches Lisa live through her fears of being “too accommodating,” wrestles with old patterns shaped by conditional love, and guides her toward setting healthy boundaries, pacing herself emotionally, and embracing playful, purposeful dating.     You'll hear: How Lisa went from feeling invisible to glowing with new confidence. Why “dating without attachment” is the most freeing mindset for re-entry. Real talk about people-pleasing, boundaries, and the power of self-worth. Actionable tips you can use to break free from old relationship patterns. If you are hiding and have some love shields up which is preventing you from dating or feeling attractive, come to Kimmy's next co-ed workshop Unleash Your Sexy Confidence: The Art of Attraction and Chemistry. to get you out there to find opportunities to build your confidence and have fun in the process.  You'll learn EXACTLY what you need to know and do in order to turn yourself into a sexy magnet.  Go to www.stophatingdating.com to register now.   Charisma Quotient Podcast is available on Apple Podcasts, Spotify, and many of your other favorite podcast channels. ************************************************⁣ Kimmy Seltzer is a Confidence Therapist and Authentic Dating Strategist implementing targeted style, emotional and social intelligence to your life. ⁣ ************************************************⁣ Would you like to connect with Kimmy?⁣ Website:  https://kimmyseltzer.com/⁣ Chat:  https://meetme.so/kimbreakthrough⁣ Instagram: @kimmyseltzer Twitter: @kimmyseltzer Join her FREE Facebook Group Love Makeover Insiders:  https://www.facebook.com/groups/lovemakeovers Take her Flirt Quiz to see what kind of flirt you are www.flirtover40.com  

Dr. Jeanette MacLean, a trailblazer in minimally invasive SDF practices, joins Dr. Joel Berg to discuss how observations and a willingness to try a different approach can positively benefit both providers and patients. Dr. MacLean shares how her own learning experiences seeing the same patients year after year in private practice led to her desire to consider less aggressive treatment options. She also delves into how the collaborative pediatric dental community was imperative in guiding her path. Guest Bio: Dr. Jeanette MacLean has been in private practice as an Owner for 20 years. As an appointee to the American Academy of Pediatric Dentistry's Speakers Bureau and has provided lectures across the United States, Canada, and Mexico, as well as webinars viewed in over 40 countries. Dr. MacLean graduated summa cum laude with a Bachelor of Science in Chemistry from Northern Arizona University in 1999. She received her dental degree, with honors, from the University of Southern California in 2003 and completed her specialty training in pediatric dentistry in 2005 at the Sunrise Children's Hospital through the University of Nevada School of Medicine. Dr. MacLean is a Fellow of the American Academy of Pediatric Dentistry, Fellow of the American College of Dentists, Fellow of the Pierre Fauchard Academy, and Diplomate of the American Board of Pediatric Dentistry. Her research has been published in the journals Pediatric Dentistry, the Journal of Clinical Pediatric Dentistry, the British Dental Journal, and Compendium. She has been featured twice in the New York Times: She is also an active member of the Central Arizona Dental Society, the Arizona Dental Association, the American Dental Association, the Arizona Academy of Pediatric Dentistry and the American Academy of Pediatric Dentistry. She is married to Timothy Budd, an attorney, and they have a son, Charlie, and a daughter, Sabrina. She has donated her time to underprivileged children both locally and in Mexico, Belize, and Costa Rica, and has been honored for her volunteer work and humanitarian achievements. She speaks conversational Spanish, and her interests include party planning, crafts, Jazzercise and all things Disney. She is also active in Local First Arizona, the Arizona Dental Associations' AHCCCS Subcommittee and Women in Dentistry group. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textIn this episode of Hallmark Mysteries and More, Andrea and Eric dig into one of the most entertaining episodes of Private Eyes yet — Season 1, Episode 7: Karaoke Confidential. What starts as a lighthearted night of karaoke quickly unravels into a mystery involving dirty cops, sketchy cover-ups, and rising tension between Shade and Angie.From Jason Priestley's smooth charm to Cindy Sampson's no-nonsense brilliance, this case has it all — suspense, heart, and just the right amount of cozy chaos. We break down the best moments, the sneaky twists, and debate whether this is the series' most fun episode to date.Whether you're a longtime Sleuther or new to Private Eyes, this episode will have you singing along… and side-eyeing every character.

In the second hour of "Dukes and Bell", the guys take a break from talking Hawks to discuss the latest trades and news in the NFL. Then, they are joined by Brian Oliver, Audacy NBA Insider, to jump back into the Hawks discussion. Da-Da Lewis closes the hour talking Bobby Bonilla Day in "Yeah Man, No Man".

Dr. Vitz talks about the blissful experience of meeting someone special. (Originally aired 07-02-2024)

In this episode of The Speak[Her] Podcast, I continue my conversation with Sealz the Man for a transparent and thought-provoking conversation exploring the difference between chemistry and compatibility—from a Black man's point of view.We unpack what truly matters when two people desire to do life together:Communication as the foundation of strong relationshipsThe importance of creating safe and healthy space to communicate —even in disagreementWhy compatibility often outweighs chemistry in building a lasting connectionThis is an honest and necessary conversation for anyone looking to grow in love, purpose, and partnership.Tune in now for insight that speaks to the heart of real relationships.Support the showFB @thespeakherpodcast | IG @camille.essick | camilleessick.com YT: CamilleEssick "Where Innovators & Creators Connect".**I do not own the rights to this music.**

In this week's episode, we're rediscovering the powerful, participatory chemistry of the early church; where love, generosity, and Spirit-led action weren't optional, they were essential. Get ready to be stirred as Pastor unpacks what it means to truly care for one another in a way that shakes the world and lifts the weary. Recorded: June 29, 2025

This is the daily Tech and Business Report. Today, KCBS Radio anchor Holly Quan spoke with Bloomberg's Brian K. Sullivan. Big cuts are coming to the National Oceanic and Atmospheric Administration, as the new budget proposal slashes the agency's budget by $1.5 billion. That will result in an estimated 2,200 jobs being cut, which is about 18% of the Administration's workforce.

Licovolt, a University College Dublin (UCD) spin-out company supported by NovaUCD, today announced that it is set to create 10 new jobs following a seed investment (undisclosed) from Davencor Holdings, established by John Corcoran, the founder and former CEO of Davenham Switchgear. Davenham, founded in 1982 and headquartered in Dublin, is a market leader of electrical distribution and control solutions for major industries, including datacentres, and was last year acquired by the Legrand Group, headquartered in France. Licovolt's technology is a novel chemical compound and associated process used to extract critical minerals from spent battery material at a fraction of the cost and emissions of current methods. The technology enables the recycling of these materials and creates a global opportunity for OEMs who manufacture cathode active material (CAM) which is required for the electric vehicle (EV) and data centre industries. Clint Zahmel, Executive Director, Licovolt said, "This investment by Davencor Holdings will enable the company to rapidly advance our strategic technology development roadmap to ensure that business development opportunities are grasped quickly given the scale of the global opportunity for Licovolt's technology. Additionally following this investment, we plan to create up to 10 new jobs over the next two years, in the areas of international business development, finance, chemical engineering and battery innovation." He added, "It is estimated that datacentres worldwide will need to recycle up to two million Uninterruptible Power Supply (UPS) battery systems over the next five years, and given John's deep understanding of the electrical and datacentre industries, together with his proven track record of building successful businesses internationally, makes him an invaluable partner as we develop and implement our international scaling strategy." John Corcoran, CEO, Davencor Holdings said, "Licovolt represents a really exciting opportunity in the field of battery recycling. The team's innovative approach and very strong technical foundation positions them well for significant growth in this evolving market." The Licovolt technology emerged after three years of intensive research, partly funded by Research Ireland, following a breakthrough chemical discovery led by Associate Professor Tony Keene, UCD School of Chemistry, in partnership with Associate Professor Steven Ferguson, UCD School of Chemical and Bioprocess Engineering, the company's co-founders. Earlier this year Licovolt entered into a formal joint development agreement with Pure Battery Technologies (PBT), headquartered in Australia with operations in Hagen, Germany. This partnership with PBT will support the rapid advancement of Licovolt's technology.

Dr. Harold McGee, PhD, is a renowned author on the topics of food chemistry and culinary science. He explains how cooking methods, types of cookware and temperature can be used to transform food and drink flavors and presents simple but powerful ways to improve nutrient availability. We also discuss how our individual biology, genetic and cultural backgrounds shape our taste preferences. Whether you're a seasoned cook or someone who simply loves to eat, our conversation will change how you think about food and cooking, give you actionable tools to try and deepen your appreciation of the experience of eating and drinking. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman Our Place: https://fromourplace.com/huberman Mateina: https://drinkmateina.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00:00 Harold McGee 00:02:21 Food Chemistry, Using Copper, Modern vs Traditional Techniques 00:09:59 Sponsors: Eight Sleep & Our Place 00:13:33 Cooking, Food & Heat, Taste & Smell 00:22:10 Umami, Savory Tastes, Braising & Meat 00:29:56 Chemistry of Cooking & Eating, Sugars & Conjugates; Slowly Enjoying Food 00:36:14 Savory Meal & Dessert; Food Course Order; Palate Cleansers 00:43:56 Salt, Baseline & Shifting Taste Preferences 00:47:18 Sponsors: AG1 & Mateina 00:50:07 Whole vs Processed Foods, Taste & Enjoyment 00:53:37 Brewing Coffee, Water Temperature, Grind Size 01:00:33 Tea & Tannins, Growing Tea Plants; Tea & Meals, Polyphenols 01:08:16 Food Combinations, Individual Tolerance; Is there an Optimal Diet? 01:11:34 Onions & Garlic, Histamines, Tool: Reduce Crying when Cutting Onions 01:13:55 Gut Sensitivities & Food, Capsaicin & Spicy Foods 01:17:21 Supertasters & Taste Buds, Bitter Taste, Chefs 01:21:57 Sponsor: Function 01:23:45 Salt & Bitter, Salting Fruit, Beer or Coffee, Warming Beer 01:26:11 Human History of Alcohol & Chocolate 01:29:25 Wine Expense vs Taste, Wine Knowledge 01:35:49 Cheese Making, Aged Cheese & Crystals, Tyrosine; Smoke Flavors, Distilling 01:44:30 Fermentation, “Stink Fish”, Caviar, Traditional & New Foods 01:50:42 Personal Journey, Astronomy, Poetry & Food 01:54:55 Beans & Gas, Tool: Soaking Beans 01:57:23 Gut Microbiome, Fermented Foods; Kids & Food Aversions 02:00:47 Cilantro & Divergent Tastes; Microwave Popcorn, Parmesan Cheese 02:04:46 John Keats Poetry, To Autumn; Acknowledgements 02:10:48 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to Episode 254 of the Pool Nation Podcast, where we're not just netting and jetting—we're building a nation of pool pros! In this myth-busting episode, Edgar, John, and Zac tackle the biggest misconceptions in pool water chemistry, breaking down what's true, what's not, and what every pool tech needs to know to protect pools, profits, and reputations. Whether you're a rookie or a veteran, you'll get actionable advice, real-world examples, and the latest science on water balance, chemical dosing, salt systems, and more. We also update you on the hottest events of the year, from the Pool Nation Awards to the $10,000 Pool Pro Challenge! Special thanks to our sponsors: SPPA, BluRay XL, AquaStar Pool Products, Natural Chemistry, Raypak, Heritage Pool Supply, Hayward, Poolside Tech, Pool Brain, Nidec, and US Motors. Their support makes this show—and your education—possible! Timestamps: [00:00] Pool Nation Intro The signature intro, sponsor shoutouts, and a Texas-sized heat check. [05:35] Summer Survival Hacks How pros handle the brutal summer heat and keep morale high on the route. [09:40] Algae Trends & Chemical Cost Warnings Why algae (especially mustard!) is tougher this year, and how to avoid skyrocketing chemical bills. [13:58] Pool Nation Event Rundown Key dates: Pop-Up Bootcamps, Pool Nation Awards, Women's Summit, Pool Pro Challenge, and Conference preview. [20:22] Business Track Sneak Peek Edgar breaks down the ONLY conference track in the industry that's 100% focused on profitability, business growth, and building high-performing teams. [26:45] Registration Details & Pro Tips How to claim your seat for business, technical, and hands-on classes—before they're gone. [30:30] Pool Chemistry Mythbusters (Rapid Fire Begins!) John takes on the top 10 pool chemistry myths, with Edgar & Zach on standby: [31:00] Myth 1: “If chlorine's good, pH doesn't matter.” [34:10] Myth 2: “Muriatic acid lowers pH and alkalinity equally.” [37:45] Myth 3: “Always correct alkalinity before pH.” [41:00] Myth 4: “Eyeball your acid or soda ash dose.” [43:36] Myth 5: “7.2 to 7.8 pH = always fine.” [46:02] Myth 6: “Strong chlorine smell means clean water.” [48:25] Myth 7: “If it looks clear, chemistry is fine.” [50:04] Myth 8: “You don't need to test CYA often.” [52:32] Myth 9: “Saltwater pools don't use chlorine.” [55:00] Myth 10: “Shock will fix any pool issue.” [58:10] Final Thoughts & Takeaways Why busting bad info is so important, and how to submit your follow-up questions. [1:01:20] Event Reminders & Sign Off How to connect with the Pool Nation crew, get registered, and join the fastest-growing pool pro community.  

Our next guest is Ryan Ponquett. Ryan has a degree in Chemistry, a master's degree in Organic Chemistry and completed four years post-graduate studies in Plant Biochemistry at the University of Natal in South Africa. He co-founded the flavour company FlavourCraft and was CEO and Technical Director for more than 20 years until it was acquired by Kerry in 2012. Ryan is a former President of the South African Association for Food Science and Technology (SAAFoST), he is an experienced flavourist and is former Kerry's VP for Taste and Innovation for the EMEA region, now with TaystOvation and Nova Genetics.Host: Trevor Groome, Séan Ryan, Michel Aubanel, Carmen Schultejans, Music: Aidan Kirkwood, Editing: Maria Palassarou, Publishing: Ján Peťka

Anthony, Ray, Skyler, and I discussed Batman: The Animated Series Season 2, episodes 6 through 10 16/81. "Harley's Holiday" 17/82. "Lock-Up" 18/83. "Make 'Em Laugh" 19/84. "Deep Freeze" 20/85. "Batgirl Returns"Follow us! Abrar: @brownboywonderpodcast, Brownboywonders Skyler: @skyler8bit, @RSR_PodcastDaniel: @RSR_Podcast, DanielMCGAnthony: @AnthonyLantern, @AnthonyReviews, The Grud PodcastRay: @TheRaySketchesFULL BATMAN TAS SCHEDULESEASON 11. "On Leather Wings"2. "The Cat and the Claw: Part I"3. "The Cat and the Claw: Part II"4. "The Last Laugh"5. "Nothing to Fear"6. "Pretty Poison"7. "The Underdwellers"8. "P.O.V."9. "The Forgotten"10. "Be a Clown"11. "Heart of Ice"12. "Two-Face: Part I"13. "Two-Face: Part II"14. "It's Never Too Late"15. "I've Got Batman in My Basement"16. "Christmas with the Joker"17. "See No Evil"18. "Beware the Gray Ghost"19. "Feat of Clay: Part I"20. "Feat of Clay: Part II"21. "Prophecy of Doom"22. "Joker's Favor"23. "Vendetta"24. "Fear of Victory"25. "The Clock King"26. "Appointment in Crime Alley"27. "Mad as a Hatter"28. "Dreams in Darkness"29. "Eternal Youth"30. "Perchance to Dream"31. "The Cape and Cowl Conspiracy"32. "Robin's Reckoning: Part I"33. "Robin's Reckoning: Part II"34. "The Laughing Fish"35. "Night of the Ninja"36. "Cat Scratch Fever"37. "The Strange Secret of Bruce Wayne"38. "Heart of Steel: Part I"39. "Heart of Steel: Part II"40. "If You're So Smart, Why Aren't You Rich?"41. "Tyger, Tyger"42. "Joker's Wild"43. "Moon of the Wolf"44. "Day of the Samurai"45. "Terror in the Sky"46. "Almost Got 'Im"47. "Birds of a Feather"48. "What Is Reality?"49. "I Am the Night"50. "Off Balance"51. "The Man Who Killed Batman"52. "Mudslide"53. "Zatanna"54. "The Mechanic"55. "Harley and Ivy"56. "Blind as a Bat"57. "His Silicon Soul"58. "Shadow of the Bat: Part I"59. "Shadow of the Bat: Part II"60. "Fire from Olympus"61. "The Demon's Quest: Part I"62. "The Demon's Quest: Part II"63. "Read My Lips"64. "The Worry Men"65. "Paging the Crime Doctor"Batman of the Phantasm (1993) SEASON 266. "Sideshow"67. "A Bullet for Bullock"68. "Trial"69. "Avatar"70. "House & Garden"71. "The Terrible Trio"72. "Harlequinade"73. "Time Out of Joint"74. "Catwalk"75. "Bane"76. "Baby-Doll"77. "The Lion and the Unicorn"78. "Showdown"79. "Riddler's Reform"80. "Second Chance"81. "Harley's Holiday"82. "Lock-Up"83. "Make 'Em Laugh"84. "Deep Freeze"85. "Batgirl Returns"Batman & Mr. Freeze: SubZero SEASON 386. "Holiday Knights"87. "Sins of the Father"88. "Cold Comfort"89. "Double Talk"90. "You Scratch My Back"91. "Never Fear"92. "Joker's Millions"93. "Growing Pains"94. "Love Is a Croc"95. "Torch Song"96. "The Ultimate Thrill"97. "Over the Edge"98. "Mean Seasons"99. "Critters"100. "Cult of the Cat"101. "Animal Act"102. "Old Wounds"103. "The Demon Within"104. "Girl's Night Out"105. "Mad Love"106. "Chemistry"107. "Beware the Creeper"108. "Judgment Day"109. "Legends of the Dark Knight"Batman: Mystery of the Batwoman 2003

06-27-25 - BR - FRI - Brady Again Trips Up On Tyroneasaurus Fun Facts And Presidents Working At McDs - Parents Need 2 Days To Recover From Traveling w/Family - SciNews On Nanobots And Space Dust And Scottish ChemistrySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Not knowing the publishing rules helped Austin Taylor sell her debut, Notes on Infinity. From lab notes to spreadsheets, learn her data-driven approach.In today's Book Gang episode, debut author Austin Taylor joins me to discuss her dazzling new novel Notes on Infinity. This high-concept campus novel follows Zoe and Jack, two brilliant students whose late-night collaboration leads to the development of an anti-aging drug, a billion-dollar startup, and a powerful reckoning.Austin brings a unique blend of rigor and vulnerability to her work, drawing from her dual background in chemistry and English, as well as personal experiences with chronic illness that reshaped her academic trajectory. Notes on Infinity may ask how far we'll go to chase our dreams, but this conversation dives into how far Austin went to write them.In this insightful conversation, Austin and I discuss:How not knowing "the rules" of publishing gave her the freedom to query an ambitious debut.The thoughtful strategies she used to distill complex scientific ideas without losing her novel's credibility—or alienating readers.The importance of chronic illness representation and how her own health challenges added urgency and emotional authenticity to the story.BONUS BOOK LIST:This week, I'm sharing a companion list of 32 Unforgettable Campus Novels With All the Drama—from ivy-draped secrets to heady student-faculty dynamics to the unsettling thrill of starting over. If Notes on Infinity sparked something for you, these book titles will keep the conversation going.Meet Austin TaylorAustin Taylor graduated from Harvard University in 2021 with a joint degree in chemistry and English. Notes on Infinity is inspired in part by her undergraduate studies, peers, and lab work in Harvard's chemistry department. She has also worked as a public speaking coach and in science policy. Austin is a private pilot, a registered Maine guide, and a bassist. She grew up in central Maine, where she now lives and writes.Mentioned in this episode:Browse the 2025 MomAdvice Summer Reading Guide (with ads) or download the 48-page reading guide ($7) to support our show. If you are a show patron, please check your inbox for your copy as part of your member benefits. Thank you for supporting my small business!  Download Today's Show TranscriptJoin the June Book Club Chat (The Reckless Oath We Made)BONUS BOOK LIST: 32 Unforgettable Campus NovelsNotes on Infinity by Austin TaylorCRISPRThe Epic of GilgameshTomorrow, and Tomorrow, and Tomorrow by Gabrielle Zevinhttps://www.instagram.com/austintaylorwrites/Bookshop.org pays a 10% commission on every sale and matches 10% to independent bookstores!Connect With Us:Join the Book Gang PatreonConnect with Austin Taylor on Instagram or her WebsiteConnect with Amy on Instagram, TikTok, or MomAdviceGet My Happy List NewsletterGet the Daily Kindle Deals NewsletterBuy Me a Coffee (for a one-time donation)

06-27-25 - BR - FRI - Brady Again Trips Up On Tyroneasaurus Fun Facts And Presidents Working At McDs - Parents Need 2 Days To Recover From Traveling w/Family - SciNews On Nanobots And Space Dust And Scottish ChemistrySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Physicist Dr Weiping Yu joins David Gornoski to talk about his upcoming book while answering questions from viewers. Is it possible to redesign the periodic table without electron shells? What implications does Uon theory have on chemistry? Can Uon theory offer a fresh take on Ray Peat's bioenergetics? Can Uon theory be converted to mathematics? How much does a soul weigh? Follow Dr Weiping Yu on X here. Follow David Gornoski on X here. Visit aneighborschoice.com for more

Jessi is STANDING ON BUSINESS in this all new episode! That business includes a full explainer of the Justin Bieber Meme “You're Not Clocking That I'm Standing On Business”, an It Ends With Update (did Blake Lively FINALLY WIN!?) an angry voicemail for Beyonce and a celebrity sighting in the wild! Plus, America's cringiest billionaires Lauren Sanchez and Jeff Bezos are getting married in Venice whether Venice wants them to or not. Jessi breaks down the celebrity guest list, the Vogue spread, the Italian protests and the shocking reason Katy Perry might not be in attendance. Speaking of weddings, it's Jessi's 11th wedding anniversary so she brings Evan on the pod against his will to celebrate! Enjoy their SIZZLING CHEMISTRY, NOW! Your Voicemails give us LIIIIIFE! Leave them anytime about ANYTHING, here: 323-448-0068 Hosted on Acast. See acast.com/privacy for more information.

Kevin Gilford's story is one of addiction, crime, survival, and redemption. In this interview, Kevin shares how he became addicted to meth, taught himself to cook it, and fell deep into the drug world — leading to time in California state prison and eventually federal prison, the same one Ian was locked up in. We dive into the realities of prison life, the underground meth scene, and how Kevin is now owning his past and rebuilding his future. #MethCookStory #PrisonSurvival #TrueCrimeInterview #AddictionRecovery #LifeAfterPrison #FederalPrisonStory #BreakingBadReality #LockedInPodcast Hosted, Executive Produced & Edited By Ian Bick: https://www.instagram.com/ian_bick/?hl=en https://ianbick.com/ Connect with Kevin Gilford: Buy his book: https://a.co/d/dq9cmdZ Facebook: https://www.facebook.com/share/1B5kRDt8do/ Presented by Tyson 2.0 & Wooooo Energy: https://tyson20.com/ https://woooooenergy.com/ Buy Merch: https://convictclothing.net/collections/convict-clothing-x-ian-bick Timestamps:00:00:00 An Unexpected Confrontation 00:06:10 Journey into using: From Discovery to Dependency00:12:23 Life as a Restaurant Cook and Cover Story 00:18:25 The Secrets of Cooking Techniques00:24:46 Chemistry 00:30:43 Struggles with Addiction and Family Life00:37:24 Experiences with a Troubling Cellmate00:43:11 Navigating Chemical Dependency and Parole 00:49:35 Negotiating Sentences and Legal Outcomes 00:55:42 East Coast vs. West Coast Jail Culture Clash01:01:49 Prison Contraband and Accountability 01:08:03 The Origin of the Nickname 'Danger'01:14:15 Navigating Job Applications with a Criminal Record 01:20:14 Life After Deportation and Reintegration01:26:32 Turning Life Around After Prison 01:33:00 Reflections on Prison Life and Hope for Change Powered by: Just Media House : https://www.justmediahouse.com/ Creative direction, design, assets, support by FWRD: https://www.fwrd.co Learn more about your ad choices. Visit megaphone.fm/adchoices

Connor and Dylan are joined by Graham Phillips (Little Shop of Horrors, 13). Suddenly, Graham y'all! The twins are gagged to have this star of stage and screen on the podcast to honor his highly anticipated return to the New York stage. But first, the boys gag over Orville Peck and Eva Noblezada in Cabaret at the Kit Kat Club. Graham is currently starring as Seymour in Little Shop of Horrors, alongside longtime friend and castmate Liz Gillies. From the workshops of 13 to the streets of Skid Row, they're finally reunited onstage. Graham discusses what it's been like joining the show, spills tea on the roles-that-almost-were over the years, and a possible clowning storyline. We ask about highlights from The Good Wife (and what he would've done on The Good Fight!), memories from Riverdale, and his film studio that he runs with his brother: Phillips Pictures. Chemistry reads with Zachary Quinto, wrap parties with Calista Flockhart and Harrison Ford, and late night karaoke sessions with Liz Gillies and 13 alums are allllll mentioned. Stick around to find out what Graham's (and Seymour Krelborn's) enneagram type is! Catch Graham in Little Shop of Horrors through July 27th only.Follow Graham on InstagramFollow DRAMA. on Twitter & Instagram & TiktokFollow Connor MacDowell on Twitter & InstagramFollow Dylan MacDowell on Twitter & InstagramSubscribe to our show on iHeartRadio Broadway! Support the podcast by subscribing to DRAMA+, which also includes bonus episodes, Instagram Close Friends content, and more!

I find there are few things as intoxicating as someone who is really interested in you. You feel they care about you, they value you, and they are curious to hear about you. This is something you can define and do, if you understand the key components. So I have an expert on listening with us. But before I introduce them, one issue that stuck out to me was, the idea of becoming and being an expert listener, is to connect. But, I don't want to connect with everyone. My goal is not to have everyone think I'm a great listener, because I don't want to connect with everyone. I don't think anyone does. I realize when I am trying to listen with endurance and tolerance when I don't really want to, I'm actually hurting the relationship. You can hear more on this in the show. My expert guest is Emily Kasriel Emily is an award-winning journalist, editor, and media executive who worked for over 20 years at the BBC. She developed the Deep Listening approach during her time as a Senior Visiting Research Fellow at King's College London's Policy Institute, building on her expertise as an accredited executive coach and workplace mediator. Emily connected with me from her home in London and I feel we had a very real and sober discussion not only about how to be an expert listener, but to be authentic about when we want to listen, or not. The 8 steps we walk through on listening come from her new book, Deep Listening: Transform Your Relationships with Family, Friends, and Foes Sign up for your $1/month trial period at shopify.com/kevin Go to shipstation.com and use code KEVIN to start your free trial. Learn more about your ad choices. Visit megaphone.fm/adchoices

We couldn't get all the way through Period Piece June and NOT do a Jane Austen movie, and we decided on Emma! The one from 1996 starring Gwyneth Paltrow, to be specific…you would not BELIEVE how many versions of Emma are out there for your consumption. Paul and Erika take you through this classic tale of gossip, matchmaking, and true love, with all the commentary and side quests you've come to love from That Aged Well!You can follow That Aged Well on Bluesky (@ThatAgedWell.bsky.social), Instagram (@ThatAgedWell), and Threads (@ThatAgedWell)!SUPPORT US ON PATREON FOR BONUS CONTENT!THAT AGED WELL MERCH!Wanna rate and review? HERE YOU GO!Hosts: Paul Caiola & Erika VillalbaProducer & Editor: Paul Caiola